CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-21 | Gorbachev Maxim Director | Grant or award · Stock Option (Right to Buy) | +12,450 | 12,450 | ||
| 2016-06-21 | Nugent Jeffrey M Director | Grant or award · Stock Option (Right to Buy) | +12,450 | 12,450 | ||
| 2016-06-21 | Nugent Jeffrey M Director | Grant or award · Stock Option (Right to Buy) | +24,590 | 24,590 | ||
| 2016-06-21 | DEMSKI MARTHA J Director | Option exercise | +16,393 | $1.13 | $19K | 16,393 |
| 2016-06-21 | DEMSKI MARTHA J Director | Grant or award · Stock Option (Right to Buy) | +12,450 | 12,450 | ||
| 2016-06-21 | DEMSKI MARTHA J Director | Grant or award · Stock Option (Right to Buy) | +16,393 | 16,393 | ||
| 2016-06-21 | DEMSKI MARTHA J Director | Option exercise · Stock Option (Right to Buy) | −16,393 | 0 | ||
| 2016-06-21 | DEMSKI MARTHA J Director | Grant or award · Stock Option (Right to Buy) | +24,590 | 24,590 | ||
| 2016-06-21 | Kamdar Kim P. Director | Grant or award · Stock Option (Right to Buy) | +12,450 | 12,450 | ||
| 2016-06-21 | Kamdar Kim P. Director | Grant or award · Stock Option (Right to Buy) | +16,393 | 16,393 | ||
| 2016-06-21 | Kamdar Kim P. Director | Grant or award · Stock Option (Right to Buy) | +24,590 | 24,590 | ||
| 2016-02-04 | Locke Kenneth W Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2016-02-04 | Knudson Susan A. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +45,000 | 45,000 | ||
| 2015-12-30 | Alta Partners VIII, L.P. Former 10% Owner | Sale | −250,000 | $1.44 | $360K | 1,339,776 |
| 2015-12-29 | Alta Partners VIII, L.P. Former 10% Owner | Sale | −493,654 | $1.53 | $755K | 1,589,776 |
| 2015-12-28 | Alta Partners VIII, L.P. Former 10% Owner | Sale | −54,333 | $1.59 | $86K | 2,083,430 |
| 2015-12-17 | Locke Kenneth W Chief Scientific Officer | Sale | −598 | $1.26 | $753 | 0 |
| 2015-12-17 | Knudson Susan A. Chief Financial Officer | Sale | −1,005 | $1.26 | $1K | 0 |
| 2015-12-15 | Alta Partners VIII, L.P. 10% owner | Sale | −529,261 | $1.44 | $762K | 2,137,763 |
| 2015-11-18 | Locke Kenneth W Chief Scientific Officer | Option exercise | +6,098 | $8.30 | $51K | 6,391 |
Page 14 of 20 · 383 trades